Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer

NCT00357760 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

94

Enrollment

NIH

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma

Interventions

BIOLOGICAL: VEGF Trap

Sponsor

National Cancer Institute (NCI)